Analysis of the efficacy and safety of the IVD/EM maintenance regimen as post-remission treatment for adult patients with T-cell lymphoblastic lymphoma/leukemia.
A maintenance therapy strategy keeps T-cell leukemia patients in remission while remaining manageable, supporting this challenging-to-treat disease.
This retrospective cohort study evaluated the IVD/EM maintenance regimen in adult T-ALL/TLL patients following induction remission, reporting disease-free survival, overall survival, and toxicity endpoints in a real-world cohort. Results support IVD/EM as an active and manageable post-remission strategy for this challenging hematologic malignancy with limited comparative data.
What the study was
- Study design
- Retrospective cohort analysis
- Category
- Other
- Maturity
- Validated
- Journal
- Leuk Res
Why it surfaced
Post-remission maintenance strategy for T-ALL/TLL published in Leukemia Research; sparse literature on optimal maintenance for this aggressive malignancy; directly addresses T1 hematologic malignancies watchlist (T-cell lineage).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.